Found 126 matching trials
Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma
NAThe study aims at:
1. Perform a multilayer analysis relying on tight integ...
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Donor CHIP and Allogeneic HSCT Outcome
N/ACurrent data on the impact of donor CHIP on long-term recipient outcome rem...
Location
The University of Hong Kong
Generation of an Induced Pluripotent Stem (iPS) Cell Bank Immune Matched to a Majority of the US Population
NAThe purpose of this study is to develop a collection of iPS cells called a ...
Location
Multiple Locations
Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Inborn Errors of Metabolism (iPSC-IEM)
N/AHuman induced pluripotent stem cells (iPSCs), are reprogrammed from somatic...
Location
Children Hospital and Institute of Child Health
Modulation of Ciliogenesis in Glioma Stem Cells
NAThe study aims at investigating the cilium-related transcriptome in patient...
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Utilizing the HITSystem for Optimizing Paediatric ART Retention and Adherence in Western Nyanza Province, Kenya
NAOverall, there are an estimated 98,000 children living with HIV in Kenya. C...
Location
Multiple Locations
Cryopreserved Hair Follicles for Disease and Cell Replacement
N/ATo explore the application of cells expanded from plucked hair follicles af...
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
PHASE2Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Location
Department of Hematology, Nanfang Hospital
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
PHASE2Background:
The mainstay of therapy for newly diagnosed multiple myeloma p...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
PHASE3This is a randomized, open label, multicenter phase III trial comparing the...
Location
Moores UC San Diego Cancer Center